Total Funding
79
69
Total FundingVenture - Series Unknown raised
Growth Score
-6 pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
27732
Inmedix brings cloud-based clinical diagnostics and immuno-autonomics to medicine to improve outcomes in autoimmune diseases and beyond.
- Glynis Thakur: Chief Revenue OfficerPast Role: Mill Creek Family Practice, Chief Executive Officer
- Andrew J Holman: CEO & Co-founder
About the Company
Inmedix has discovered and is commercializing a novel class of diagnostics and therapeutics. Their approach focuses on autonomic nervous system (ANS) control of stress responses within the brain. In the setting of an autoimmune disease, ANS stress can significantly intensify an autoimmune disease. They call it Immuno-autonomics. They seek to
understand and block this process to allow current autoimmune disease therapies to work much better.
